Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.
暂无分享,去创建一个
S. Ethier | S. Harvey | Y. Gong | S P Ethier | D A Zajchowski | A Munishkin | M F Bartholdi | Y Gong | L Webster | H L Liu | C Beauheim | S Harvey | P H Johnson | H. Liu | M. Bartholdi | L. Webster | D. Zajchowski | P. Johnson | C. Beauheim | A. Munishkin
[1] E. Gelmann,et al. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. , 1994, Cancer research.
[2] Jeffrey M. Skerker,et al. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. , 1992, Cancer research.
[3] R. Moll,et al. Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas , 1998, Virchows Archiv.
[4] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[5] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[6] G. Landes,et al. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. , 1999, Cancer research.
[7] J. McClary,et al. The novel estrogen-responsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant. , 1998, Molecular endocrinology.
[8] K. Milde-Langosch,et al. Expression pattern of the AP‐1 family in breast cancer: Association of fosB expression with a well‐differentiated, receptor‐positive tumor phenotype , 1999, International journal of cancer.
[9] M J O'Hare,et al. Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.
[10] P. Gullino,et al. Angiogenesis and neoplastic progression in vitro. , 1982, Journal of the National Cancer Institute.
[11] M. Schena. Genome analysis with gene expression microarrays. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[12] T. Soussi,et al. Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information. , 1985, Experimental cell research.
[13] E. Gelmann,et al. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[14] G. Martin,et al. Basement membrane and the invasive activity of metastatic tumor cells. , 1986, Journal of the National Cancer Institute.
[15] E. Gelmann,et al. Alterations in β-Catenin Phosphorylation and Plakoglobin Expression in Human Breast Cancer Cells , 1994 .
[16] R. Weigel,et al. GATA‐3 is expressed in association with estrogen receptor in breast cancer , 1999, International journal of cancer.
[17] C. Gilles,et al. The Epithelial to Mesenchymal Transition and Metastatic Progression in Carcinoma , 1996 .
[18] P. Brown,et al. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype , 1999, Oncogene.
[19] V. Band,et al. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Bittner,et al. Expression profiling using cDNA microarrays , 1999, Nature Genetics.
[21] E. Lengyel,et al. Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] E. Gelmann,et al. Regulation of vimentin gene transcription in human breast cancer cell lines. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[23] G. Laurie,et al. Basement membrane complexes with biological activity. , 1986, Biochemistry.
[24] Robert Clarke,et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.
[25] Christian A. Rees,et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[27] J. Price,et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.
[28] B. Weber,et al. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. , 1993, Cancer research.
[29] R. Sager,et al. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. , 1993, Cancer research.
[30] M. Johnston,et al. Gene chips: Array of hope for understanding gene regulation , 1998, Current Biology.
[31] Jean-Michel,et al. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. , 1998, Cancer research.
[32] H. Nguyen,et al. Effects of cell cycle, wild-type p53 and DNA damage on p21CIP1/Waf1 expression in human breast epithelial cells. , 1995, Oncogene.
[33] L. Liotta,et al. General mechanisms of metastasis , 1997, Cancer.
[34] S. Ethier,et al. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. , 1996, Cancer research.
[35] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.
[36] E. Hay. An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.
[37] P. Liang,et al. Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] M. Hendrix,et al. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. , 1997, The American journal of pathology.
[39] S. Pileri,et al. DIFFERENTIATION PATHWAYS IN PRIMARY INVASIVE BREAST CARCINOMA AS SUGGESTED BY INTERMEDIATE FILAMENT AND BIOPATHOLOGICAL MARKER EXPRESSION , 1996, The Journal of pathology.
[40] L. Engel,et al. Human breast carcinoma cells in continuous culture: a review. , 1978, Cancer research.
[41] P. Yaswen,et al. Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Stampfer,et al. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[43] V. Berezin,et al. Fra-1 Induces Morphological Transformation and Increases In Vitro Invasiveness and Motility of Epithelioid Adenocarcinoma Cells , 1998, Molecular and Cellular Biology.
[44] M. Bissell,et al. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. Jove,et al. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. , 1997, Cancer research.
[46] J. Hudson,et al. In vivo gene expression profile analysis of human breast cancer progression. , 1999, Cancer research.
[47] O. Kallioniemi,et al. Molecular cytogenetic analysis of 11 new breast cancer cell lines , 1999, British Journal of Cancer.